The Michael J. Fox Foundation for Parkinson's Research Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • The Michael J. Fox Foundation for Parkinson's Research's estimated annual revenue is currently $48.8M per year.(i)
  • The Michael J. Fox Foundation for Parkinson's Research's estimated revenue per employee is $129,540

Employee Data

  • The Michael J. Fox Foundation for Parkinson's Research has 377 Employees.(i)
  • The Michael J. Fox Foundation for Parkinson's Research grew their employee count by 10% last year.

The Michael J. Fox Foundation for Parkinson's Research's People

NameTitleEmail/Phone
1
Deputy CEOReveal Email/Phone
2
Co-Founder and CEOReveal Email/Phone
3
Chief StaffReveal Email/Phone
4
Director, Office the Chief ScientistReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Chief Development OfficerReveal Email/Phone
7
Chief People OfficerReveal Email/Phone
8
SVP Brand MarketingReveal Email/Phone
9
SVP Public PolicyReveal Email/Phone
10
SVP AnalyticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M150%N/AN/A
#2
$1.9M27-13%N/AN/A
#3
$6.9M7510%N/AN/A
#4
$10.7M10533%N/AN/A
#5
$0.7M12-8%N/AN/A
#6
$1M16-6%N/AN/A
#7
$67.7M5315%N/AN/A
#8
$1.7M2414%N/AN/A
#9
$2992.5M20956N/AN/AN/A
#10
$11.2M110-6%N/AN/A
Add Company

What Is The Michael J. Fox Foundation for Parkinson's Research?

The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.

keywords:N/A

N/A

Total Funding

377

Number of Employees

$48.8M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Michael J. Fox Foundation for Parkinson's Research News

2022-04-17 - Neuropore Therapies Awarded $4.8M Grant from The Michael ...

... Grant from The Michael J. Fox Foundation for Parkinson's Research to ... of Parkinson's disease and other neurodegenerative disorders,...

2022-04-17 - MJFF Names German Neurologist as Winner of 2022 ...

Mollenhauer's work has focused on developing biomarkers of early stage, or prodromal, Parkinson's, as well as those tracking disease progression...

2022-03-30 - Nitrase Therapeutics Receives New Grant from The Michael J ...

Fox Foundation for Parkinson's Research (MJFF). This grant was awarded to fund Nitrase's continued research on a novel biomarker identified by...

2021-10-28 - Gain Therapeutics to Present at Upcoming Medical Conferences

- The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Webinars - - Society of Neuroscience 50th Anniversary Meeting – BETHESDA, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying ...

2021-04-20 - The Michael J. Fox Foundation for Parkinson's Research Adds Melanie Bolch Isbill, Alex Krys and Jack Quinn to Its Board of Directors

NEW YORK, April 20, 2021 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that during its Board meeting on March 11, 2021, three new members were appointed to the Board of Directors — Melanie Bolch Isbill, Alex Krys and Jack Quinn. Each provides a diverse a ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$108.7M37782%$165M
#2
$591.4M3777%N/A
#3
$107.3M378-1%N/A
#4
$62.6M379-13%$178M
#5
$118.4M3792%N/A